Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status [Corrigendum]
Fireman Klein E, Adir Y, Krencel A, et al. Int J Chron Obstruct Pulmon Dis. 2019;14:557–564.
The authors have advised that they neglected to mention an acknowledgment for the department in which the research took place, in good faith. The complete acknowledgment details (page 563) are as follows:
This work was supported by the Israel Lung Association. We would like to express our deepest gratitude and appreciation to Professor Elad Schiff and the Internal Medicine B Department at the Bnai Zion Medical Center for support, mentoring, and making this study possible.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]